Chronic drug shortages impact patient care across the United States. Our mission is to provide quality generic medicines that are available and affordable to everyone.
Member hospital teams and their patients now have reliable access to over 40 Civica medicines, including those used to help fight COVID-19.
Civica Rx was established in 2018 to address a persistent drug shortage problem that has become a national crisis for hospitals and patients. Civica, a mission-driven, not-for-profit, non-stock generic drug company, was founded by leading hospital systems that know first-hand about the impact of the inconsistent, unpredictable, and often unstable market dynamics that lead...
Civica Rx CEO Martin VanTrieste participated in the November 27th, 2018 FDA Workshop on Drug Shortages at Duke University. ...
Martin was recently a key note speaker at the American Society of Consultant Pharmacists (ASCP) Annual Meeting and participated in a post-event podcast, where he shared information about Civica's plans to ensure hospital patients are able to receive the medicines they need, when they need them. Listen here. They also asked him for tips on how to...
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.